Methylene Blue



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 22.1%
Parathyroidectomy 14.0%
Parathyroid Disorder 12.8%
Diagnostic Procedure 11.6%
Scan Parathyroid 10.5%
Surgery 5.8%
Depression 3.5%
Parathyroid Gland Operation 3.5%
Vasoplegia Syndrome 3.5%
Anxiety 1.2%
Cataract Operation 1.2%
Cecal Polyp 1.2%
Drug Use For Unknown Indication 1.2%
Laboratory Test 1.2%
Local Anaesthesia 1.2%
Lung Disorder 1.2%
Lymph Node Disorder 1.2%
Obsessive-compulsive Disorder 1.2%
Parathyroid Tumour 1.2%
Scan 1.2%
Off Label Use 16.1%
Vomiting 16.1%
Serotonin Syndrome 12.9%
Post Procedural Complication 9.7%
Toxicity To Various Agents 6.5%
Unresponsive To Stimuli 4.8%
Vision Blurred 4.8%
Laboratory Test Interference 3.2%
Pulseless Electrical Activity 3.2%
Skin Lesion 3.2%
Vertigo 3.2%
White Blood Cell Count Increased 3.2%
Anaphylactic Shock 1.6%
Encephalopathy 1.6%
Hypoxia 1.6%
Immediate Post-injection Reaction 1.6%
Infusion Site Haemorrhage 1.6%
Injection Site Pain 1.6%
Injection Site Reaction 1.6%
Lymphorrhoea 1.6%
Secondary
Drug Use For Unknown Indication 28.7%
Parathyroidectomy 11.5%
Depression 11.0%
Sedation 8.2%
Analgesia 5.9%
Preoperative Care 5.4%
Product Used For Unknown Indication 5.4%
Anaesthesia 4.8%
Analgesic Therapy 2.8%
Induction Of Anaesthesia 2.3%
Scan Parathyroid 2.3%
Lymphoma 2.0%
General Anaesthesia 1.7%
Drug Exposure In Utero 1.4%
Maintenance Of Anaesthesia 1.4%
Parathyroid Disorder 1.4%
Antiemetic Supportive Care 1.1%
General Anesthesia 1.1%
Antidepressant Therapy 0.8%
Encephalopathy 0.8%
Serotonin Syndrome 34.1%
White Blood Cell Count Increased 14.8%
Vomiting 9.1%
Staring 6.8%
Drug Interaction 5.7%
Toxic Encephalopathy 4.5%
Tremor 4.5%
Inhibitory Drug Interaction 3.4%
Premature Baby 2.3%
Unresponsive To Stimuli 2.3%
Vision Blurred 2.3%
Bone Marrow Failure 1.1%
Exposure During Pregnancy 1.1%
Mental Disorder 1.1%
Mydriasis 1.1%
Nystagmus 1.1%
Parathyroid Tumour Benign 1.1%
Premature Delivery 1.1%
Pyrexia 1.1%
Skin Discolouration 1.1%
Concomitant
Product Used For Unknown Indication 34.0%
Prophylaxis 8.8%
Urinary Tract Infection 8.8%
Peritoneal Dialysis 6.8%
Chemotherapy 5.4%
Lymphoma 4.8%
Diffuse Large B-cell Lymphoma 3.4%
Parathyroidectomy 3.4%
Premedication 3.4%
Neoplasm Malignant 2.7%
Pain 2.7%
Antibiotic Level 2.0%
Antiemetic Supportive Care 2.0%
Constipation 2.0%
Coronary Artery Bypass 2.0%
Maintenance Of Anaesthesia 2.0%
Anaesthesia Reversal 1.4%
Anxiety 1.4%
B-cell Lymphoma 1.4%
Blood Pressure Systolic Decreased 1.4%
Vomiting 14.7%
Sclerosing Encapsulating Peritonitis 11.8%
Serotonin Syndrome 8.8%
Blood Creatinine Increased 5.9%
Hyponatraemia 5.9%
Methaemoglobinaemia 5.9%
Myositis 5.9%
Visual Impairment 5.9%
Abdominal Pain 2.9%
Anhedonia 2.9%
Device Related Infection 2.9%
Electrocardiogram St-t Segment Elevation 2.9%
Encephalopathy 2.9%
Febrile Neutropenia 2.9%
Gastrointestinal Haemorrhage 2.9%
Hypotension 2.9%
Multi-organ Failure 2.9%
Nausea 2.9%
Pain 2.9%
Post Procedural Complication 2.9%
Interacting
Chemotherapy 12.9%
Parathyroidectomy 12.9%
Product Used For Unknown Indication 12.9%
Analgesic Therapy 8.1%
Surgery 8.1%
Antiemetic Supportive Care 4.8%
Depression 4.8%
Depressive Symptom 4.8%
Nausea 4.8%
Diagnostic Procedure 3.2%
Drug Use For Unknown Indication 3.2%
Encephalopathy 3.2%
Parathyroid Gland Operation 3.2%
Vomiting 3.2%
Agitation 1.6%
Antidepressant Therapy 1.6%
Breast Cancer 1.6%
Confusional State 1.6%
Imaging Procedure 1.6%
Parathyroid Tumour 1.6%
Serotonin Syndrome 56.3%
Nystagmus 12.5%
Unresponsive To Stimuli 12.5%
Agitation 6.3%
Dyskinesia 6.3%
Tachycardia 6.3%